These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 4374654

  • 1. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D, Kraft D, Schaefer K, Krempien B.
    MMW Munch Med Wochenschr; 1974 Sep 13; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract] [Full Text] [Related]

  • 2. Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
    Brickman AS, Coburn JW, Sherrard DJ, Wong EG, Norman AW, Singer FR.
    Contrib Nephrol; 1980 Sep 13; 18():29-41. PubMed ID: 7353378
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
    Brickman AS, Norman AW.
    Kidney Int; 1973 Aug 13; 4(2):161-7. PubMed ID: 4364427
    [No Abstract] [Full Text] [Related]

  • 4. Editorial: Azotaemic renal osteodystrophy.
    Med J Aust; 1974 Jun 01; 1(22):864-5. PubMed ID: 4851493
    [No Abstract] [Full Text] [Related]

  • 5. Editorial: Role of the kidney in the metabolism of calciferol (vitamin D).
    Coburn JW, Norman AW.
    Clin Nephrol; 1973 Jun 01; 1(5):273-83. PubMed ID: 4358418
    [No Abstract] [Full Text] [Related]

  • 6. The use of metabolites and analogues of vitamin D in prospective renal transplant recipients.
    Cundy T, Kanis JA, Fraher L, Clemens TL, O'Riordan JL.
    Clin Nephrol; 1981 May 01; 15(5):240-5. PubMed ID: 7018772
    [No Abstract] [Full Text] [Related]

  • 7. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W, Graben N, Merguet P.
    Verh Dtsch Ges Inn Med; 1981 May 01; 83():1307-10. PubMed ID: 611841
    [No Abstract] [Full Text] [Related]

  • 8. Requirements of vitamin D metabolites in patients with renal disease.
    Massry SG.
    Am J Clin Nutr; 1980 Jul 01; 33(7):1530-5. PubMed ID: 6893103
    [No Abstract] [Full Text] [Related]

  • 9. Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.
    de Fremont JF, Sebert JL, Gueris J, Marie P, Coevoet B, Makdassi R, Lambrey G, Meunier P, Fournier A.
    Proc Eur Dial Transplant Assoc; 1979 Jul 01; 16():675-6. PubMed ID: 232918
    [No Abstract] [Full Text] [Related]

  • 10. [Disorders of calcium metabolism in kidney failure].
    Ritz E, Krempien B, Andrassy K.
    Med Klin; 1972 Sep 08; 67(36):1129-32. PubMed ID: 4561354
    [No Abstract] [Full Text] [Related]

  • 11. [Current problems of azotemic bone diseases].
    Schaefer K, Opitz A.
    Dtsch Med Wochenschr; 1970 Jan 09; 95(2):84-8. PubMed ID: 4902985
    [No Abstract] [Full Text] [Related]

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 09; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 13. Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.
    Sherrard DJ, Coburn JW, Brickman AS, Singer FR, Maloney N.
    Contrib Nephrol; 1980 Nov 09; 18():92-7. PubMed ID: 7353382
    [No Abstract] [Full Text] [Related]

  • 14. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS, Slatopolsky E, Reiss E, Avioli LV.
    Arch Intern Med; 1969 May 09; 123(5):543-53. PubMed ID: 4888973
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of renal osteodystrophy with 25-hydroxycholecalciferol.
    DeLuca HF, Avioli LV.
    Arch Intern Med; 1970 Nov 09; 126(5):896-9. PubMed ID: 4319937
    [No Abstract] [Full Text] [Related]

  • 16. The nature of vitamin D resistance in experimental uremia.
    Kimberg DV, Baerg RD, Gershon E.
    Arch Intern Med; 1970 Nov 09; 126(5):891-5. PubMed ID: 4319936
    [No Abstract] [Full Text] [Related]

  • 17. Indications for parathyroidectomy in advanced renal disease.
    Buck BA, Robertson RD.
    Surg Gynecol Obstet; 1971 Aug 09; 133(2):218-24. PubMed ID: 4935588
    [No Abstract] [Full Text] [Related]

  • 18. Azotemic osteodystrophy - indications for intervention.
    Ritz E.
    Prog Biochem Pharmacol; 1980 Aug 09; 17():251-8. PubMed ID: 7208504
    [Abstract] [Full Text] [Related]

  • 19. [The metabolic effect of vitamins D in chronic renal insufficiency (author's transl)].
    Hrba J, Wilczek H, Pacovský V, Ston J.
    Sb Lek; 1975 Jul 09; 77(7):198-204. PubMed ID: 169565
    [No Abstract] [Full Text] [Related]

  • 20. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD, Gerlach W, Henning HV, Emrich D, Scheler F, Kattermann R.
    Dtsch Med Wochenschr; 1972 Nov 10; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.